Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Cancer Res. 2017 Apr 12;77(11):2927–2937. doi: 10.1158/0008-5472.CAN-16-3351

Figure 3.

Figure 3

Immunostaining of CCND2 and MUC5AC in mouse and human CDS and ES. A, mCDShows positive staining for CCND2, ETV4 and MUC5AC (left). No expression for CCND2 and MUC5AC and little expression for ETV4 in mES (center). Scale bars indicate 40 μm. The frequencies of positive cells for CCND2, MUC5AC or ETV4 were quantitated (right). B, Human CIC-rearranged sarcoma (hCIC) shows CCND2 and MUC5AC expression (left). No expression in hES (center). Scale bars indicate 40 μm. The frequencies of positive cells for CCND2 or MUC5AC in hCIC, hES, rhabdomyosarcoma (hRS), extraskeletal myxoid chondrosarcoma (hEMCS) and synovial sarcoma (hSS) were quantitated (right). The numbers of cases are indicated in parentheses.